Matador Resources Company Declares Quarterly Cash Dividend
DALLAS–(BUSINESS WIRE)–Matador Resources Company (NYSE: MTDR) (“Matador”) today announced that its Board of Directors declared a quarterly cash dividend... Read more.
Matador Resources Company Declares Quarterly Cash Dividend
DALLAS–(BUSINESS WIRE)–Matador Resources Company (NYSE: MTDR) (“Matador”) today announced that its Board of Directors declared a quarterly cash dividend... Read more.
TriplePoint Venture Growth BDC Corp. to Announce 2024 First Quarter Financial Results on Wednesday, May 1, 2024
MENLO PARK, Calif.–(BUSINESS WIRE)–TriplePoint Venture Growth BDC Corp. (NYSE: TPVG) (the “Company”), the leading financing provider to venture growth... Read more.
Universal Display Corporation Receives 2024 Outstanding Strategic Partner Award from BOE
EWING, N.J.–(BUSINESS WIRE)–$OLED #OLED—Universal Display Corporation (Nasdaq: OLED) (UDC), enabling energy-efficient displays and lighting with... Read more.
Tutor Perini Prices $400 Million of Senior Notes
LOS ANGELES–(BUSINESS WIRE)–Tutor Perini Corporation (NYSE: TPC) (the “Company”), a leading civil, building and specialty construction company, announced... Read more.
Affirm to Announce Third Quarter Fiscal Year 2024 Results on May 8, 2024
SAN FRANCISCO–(BUSINESS WIRE)–Affirm Holdings, Inc. (NASDAQ: AFRM), the payment network that empowers consumers and helps merchants drive growth, today... Read more.
Kinder Morgan Reports First Quarter 2024 Financial Results
Earnings per Share up 10%; Adjusted Earnings per Share up 13% Approves Cash Dividend of $0.2875 Per Share ($1.15 Annualized) HOUSTON–(BUSINESS WIRE)–Kinder... Read more.
Acadia Pharmaceuticals Presents New DAYBUE™ (trofinetide) Clinical Data at the 2024 American Academy of Neurology (AAN) Annual Meeting
SAN DIEGO–(BUSINESS WIRE)–Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that two oral presentations featuring DAYBUE™ (trofinetide) findings... Read more.
Chegg Reports New Hire Equity Grants Under NYSE Rule 303A.08
SANTA CLARA, Calif.–(BUSINESS WIRE)–Chegg, Inc. (NYSE:CHGG), the leading student-first connected learning platform, today announced that on April 12,... Read more.
Evolus Announces Publication of Safety and Duration Data from Phase 2 Study for “Extra-Strength” 40U Formulation of Jeuveau®
The article published in Aesthetic Surgery Journal supports safety and duration of effect for temporary improvement in the appearance of moderate to severe glabellar... Read more.